Atrasentan for the Treatment of IgA Nephropathy: Interim Results From the AFFINITY Study

Authors
Category Primary study
JournalJournal of the American Society of Nephrology
Year 2022
This article has no abstract
Epistemonikos ID: 4e113e112fbd7ccfba2463d1b9436b6fa26b77b2
First added on: Feb 15, 2025